Acadia Healthcare (NASDAQ:ACHC) Shares Gap Down on Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) gapped down prior to trading on Thursday after Bank of America lowered their price target on the stock from $105.00 to $90.00. The stock had previously closed at $72.99, but opened at $70.14. Bank of America currently has a buy rating on the stock. Acadia Healthcare shares last traded at $69.04, with a volume of 323,695 shares changing hands.

Other equities research analysts also recently issued reports about the company. UBS Group increased their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a "buy" rating in a research report on Wednesday, February 28th. TD Cowen raised their target price on Acadia Healthcare from $86.00 to $101.00 and gave the company an "outperform" rating in a research report on Friday, March 1st. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "sell" rating to a "hold" rating and set a $70.00 target price on the stock in a research report on Thursday, April 25th. Barclays dropped their target price on Acadia Healthcare from $100.00 to $91.00 and set an "overweight" rating on the stock in a research report on Thursday. Finally, Stephens upgraded Acadia Healthcare from an "equal weight" rating to an "overweight" rating and set a $92.00 target price on the stock in a research report on Friday, January 5th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $90.90.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the firm's stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company's stock, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Headlands Technologies LLC purchased a new position in Acadia Healthcare in the 3rd quarter worth approximately $25,000. GAMMA Investing LLC purchased a new position in Acadia Healthcare in the 4th quarter worth approximately $26,000. Mather Group LLC. purchased a new position in Acadia Healthcare in the 1st quarter worth approximately $48,000. Fifth Third Bancorp lifted its stake in Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company's stock worth $52,000 after purchasing an additional 136 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new position in Acadia Healthcare in the 3rd quarter worth approximately $96,000.

Acadia Healthcare Trading Down 8.6 %

The stock has a market cap of $6.17 billion, a PE ratio of -269.63, a price-to-earnings-growth ratio of 2.18 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The company's 50-day moving average price is $77.49 and its 200 day moving average price is $77.68.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.80 by $0.04. The firm had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business's revenue for the quarter was up 9.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.75 EPS. On average, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.